Literature DB >> 2045829

5-HT in migraine--an introduction.

P R Saxena1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2045829     DOI： 10.1007/bf01642904

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances.

Authors:  P R Saxena; P van Houwelingen; I L Bonta
Journal:  Eur J Pharmacol       Date:  1971       Impact factor: 4.432

2.  Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

Authors:  P B Bradley; G Engel; W Feniuk; J R Fozard; P P Humphrey; D N Middlemiss; E J Mylecharane; B P Richardson; P R Saxena
Journal:  Neuropharmacology       Date:  1986-06       Impact factor: 5.250

3.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

4.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.

Authors:  S J Peroutka; S H Snyder
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

Review 5.  5-HT(1)-like receptor agonists and the pathophysiology of migraine.

Authors:  P R Saxena; M D Ferrari
Journal:  Trends Pharmacol Sci       Date:  1989-05       Impact factor: 14.819

6.  Two kinds of tryptamine receptor.

Authors:  J H GADDUM; Z P PICARELLI
Journal:  Br J Pharmacol Chemother       Date:  1957-09
  6 in total
  1 in total

Review 1.  Childhood functional abdominal pain: mechanisms and management.

Authors:  Judith Korterink; Niranga Manjuri Devanarayana; Shaman Rajindrajith; Arine Vlieger; Marc A Benninga
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-10       Impact factor: 46.802
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.